Fig. 2 | Scientific Reports

Fig. 2

From: Exploring the active ingredients of Banzhilian and its mechanism of action on diabetic Gastric cancer based on network pharmacology

Fig. 2

Prediction of Banzhilian’s components and targets in anti-GC-diabetes, along with GO and KEGG analysis. (A) Diabetes-related genes. (B) GC-related genes. (C) Identification of intersection targets between Banzhilian and GC-diabetes. (D) Interaction between Banzhilian’s active components and GC-diabetes pathogenic genes. (E,F) Key targets were identified using the CytoNCA plugin. (G) GO analysis. (H) KEGG enrichment analysis.

Back to article page